BUY Grasim Industries Limited — Manas Jaiswal
Grasim Industries share price target & all analyst calls
byManas JaiswalHorizon: 1–3 months22 Apr 2026via CNBC Awaaz.
Entry₹2,803Inferred
Stop loss₹2,700-3.67% risk
Exit₹3,00011 May 2026, 12:05 pm
Follow Manas Jaiswal for new calls(34% target hit, 38 closed calls)Get alertsWatch GRASIM for new buy/sell callsGet alertsSee 2 active Short-term calls on GRASIM
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 supporting1 neutral0 opposing
Supports the BUY call (1)
3 advisors have active long-term BUY calls on this stock
Advisor consensus · adjacent horizon·11 Feb · 3mo ago
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Grasim Industries
- BUY — Sumeet Bagadia, Choice Broking19 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- BUY — Sandeep Jain, Tradeswift19 Oct 2026 · Same day · target ₹2,990 · SL hit
- BUY — Sumeet Bagadia, Choice Broking17 Oct 2026 · ~2 weeks · target ₹3,240 · Active
- BUY — Sumeet Bagadia, Choice Broking24 Sept 2026 · Same day · target ₹3,250 · Expired
- SELL — Rakesh Bansal17 Sept 2026 · Next day · target ₹3,100 · Expired
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

